TITAN PHARMACEUTICALS INC Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Titan Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Titan Pharmaceuticals Inc Return On Assets for the quarter ending June 30, 2024 was -75.1 %, a 70.5% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Return On Assets for 2023 was -106 %, a 25% increase from 2022.
  • Titan Pharmaceuticals Inc annual Return On Assets for 2022 was -141 %, a 72.5% decline from 2021.
  • Titan Pharmaceuticals Inc annual Return On Assets for 2021 was -81.7 %, a 56.2% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -75.1 +179 +70.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -77.6 +102 +56.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -106 +35.2 +25% Oct 1, 2023 Dec 31, 2023
Q3 2023 -145 -21 -17% Jul 1, 2023 Sep 30, 2023
Q2 2023 -254 -150 -144% Apr 1, 2023 Jun 30, 2023
Q1 2023 -179 -91.5 -104% Jan 1, 2023 Mar 31, 2023
Q4 2022 -141 -59.2 -72.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -124 -37.2 -42.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -104 +14.8 +12.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -88 +66.2 +43% Jan 1, 2022 Mar 31, 2022
Q4 2021 -81.7 +105 +56.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -86.6 +102 +54% Jul 1, 2021 Sep 30, 2021
Q2 2021 -119 +60.2 +33.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -154 +47 +23.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -186 +12.9 +6.45% Oct 1, 2020 Dec 31, 2020
Q3 2020 -188 -17.9 -10.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -179 -41.1 -29.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -201 -97 -93.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -199 -98.7 -98% Oct 1, 2019 Dec 31, 2019
Q3 2019 -170 -50.7 -42.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -138 +5.29 +3.69% Apr 1, 2019 Jun 30, 2019
Q1 2019 -104 +48.9 +32% Jan 1, 2019 Mar 31, 2019
Q4 2018 -101 +29 +22.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -120 -23.4 -24.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -144 -73.1 -104% Apr 1, 2018 Jun 30, 2018
Q1 2018 -153 -173 -875% Jan 1, 2018 Mar 31, 2018
Q4 2017 -130 -156 -602% Oct 1, 2017 Dec 31, 2017
Q3 2017 -96.3 -124 -445% Jul 1, 2017 Sep 30, 2017
Q2 2017 -70.5 -107 -293% Apr 1, 2017 Jun 30, 2017
Q1 2017 19.7 +77 Jan 1, 2017 Mar 31, 2017
Q4 2016 25.8 +96.5 Oct 1, 2016 Dec 31, 2016
Q3 2016 27.9 +80.8 Jul 1, 2016 Sep 30, 2016
Q2 2016 36.5 +76.3 Apr 1, 2016 Jun 30, 2016
Q1 2016 -57.2 -24.3 -73.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -70.6 -55.7 -373% Oct 1, 2015 Dec 31, 2015
Q3 2015 -52.9 -39.1 -284% Jul 1, 2015 Sep 30, 2015
Q2 2015 -39.8 -14.9 -59.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -33 -44.3 -390% Jan 1, 2015 Mar 31, 2015
Q4 2014 -14.9 -67.1 -129% Oct 1, 2014 Dec 31, 2014
Q3 2014 -13.8 -61.5 -129% Jul 1, 2014 Sep 30, 2014
Q2 2014 -24.9 -39.5 -271% Apr 1, 2014 Jun 30, 2014
Q1 2014 11.4 +34.6 Jan 1, 2014 Mar 31, 2014
Q4 2013 52.2 +167 Oct 1, 2013 Dec 31, 2013
Q3 2013 47.7 +233 Jul 1, 2013 Sep 30, 2013
Q2 2013 14.6 +138 Apr 1, 2013 Jun 30, 2013
Q1 2013 -23.2 +168 +87.9% Jan 1, 2013 Mar 31, 2013
Q4 2012 -114 Oct 1, 2012 Dec 31, 2012
Q3 2012 -185 Jul 1, 2012 Sep 30, 2012
Q2 2012 -123 Apr 1, 2012 Jun 30, 2012
Q1 2012 -191 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.